Global In-vitro Diagnostic Services Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Infectious Testing
  • 1.2.3 Diabetes Testing
  • 1.2.4 Molecular Testing
  • 1.2.5 Tissue Testing
• 1.3 Market by Application
  • 1.3.1 Global In-vitro Diagnostic Services Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Point-Of-Care Testing
  • 1.3.4 Laboratories
  • 1.3.5 Academic Institutes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global In-vitro Diagnostic Services Market Perspective (2016-2027)
• 2.2 In-vitro Diagnostic Services Growth Trends by Regions
  • 2.2.1 In-vitro Diagnostic Services Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 In-vitro Diagnostic Services Historic Market Share by Regions (2016-2021)
  • 2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Regions (2022-2027)
• 2.3 In-vitro Diagnostic Services Industry Dynamic
  • 2.3.1 In-vitro Diagnostic Services Market Trends
  • 2.3.2 In-vitro Diagnostic Services Market Drivers
  • 2.3.3 In-vitro Diagnostic Services Market Challenges
  • 2.3.4 In-vitro Diagnostic Services Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top In-vitro Diagnostic Services Players by Revenue
  • 3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2016-2021)
  • 3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2016-2021)
• 3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
• 3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
  • 3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2020
• 3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
• 3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
• 3.7 Date of Enter into In-vitro Diagnostic Services Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 In-vitro Diagnostic Services Breakdown Data by Type

• 4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2016-2021)
• 4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2022-2027)

5 In-vitro Diagnostic Services Breakdown Data by Application

• 5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2016-2021)
• 5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America In-vitro Diagnostic Services Market Size (2016-2027)
• 6.2 North America In-vitro Diagnostic Services Market Size by Type
  • 6.2.1 North America In-vitro Diagnostic Services Market Size by Type (2016-2021)
  • 6.2.2 North America In-vitro Diagnostic Services Market Size by Type (2022-2027)
  • 6.2.3 North America In-vitro Diagnostic Services Market Size by Type (2016-2027)
• 6.3 North America In-vitro Diagnostic Services Market Size by Application
  • 6.3.1 North America In-vitro Diagnostic Services Market Size by Application (2016-2021)
  • 6.3.2 North America In-vitro Diagnostic Services Market Size by Application (2022-2027)
  • 6.3.3 North America In-vitro Diagnostic Services Market Size by Application (2016-2027)
• 6.4 North America In-vitro Diagnostic Services Market Size by Country
  • 6.4.1 North America In-vitro Diagnostic Services Market Size by Country (2016-2021)
  • 6.4.2 North America In-vitro Diagnostic Services Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe In-vitro Diagnostic Services Market Size (2016-2027)
• 7.2 Europe In-vitro Diagnostic Services Market Size by Type
  • 7.2.1 Europe In-vitro Diagnostic Services Market Size by Type (2016-2021)
  • 7.2.2 Europe In-vitro Diagnostic Services Market Size by Type (2022-2027)
  • 7.2.3 Europe In-vitro Diagnostic Services Market Size by Type (2016-2027)
• 7.3 Europe In-vitro Diagnostic Services Market Size by Application
  • 7.3.1 Europe In-vitro Diagnostic Services Market Size by Application (2016-2021)
  • 7.3.2 Europe In-vitro Diagnostic Services Market Size by Application (2022-2027)
  • 7.3.3 Europe In-vitro Diagnostic Services Market Size by Application (2016-2027)
• 7.4 Europe In-vitro Diagnostic Services Market Size by Country
  • 7.4.1 Europe In-vitro Diagnostic Services Market Size by Country (2016-2021)
  • 7.4.2 Europe In-vitro Diagnostic Services Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2016-2027)
• 8.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type
  • 8.2.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2027)
• 8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application
  • 8.3.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2027)
• 8.4 Asia-Pacific In-vitro Diagnostic Services Market Size by Region
  • 8.4.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America In-vitro Diagnostic Services Market Size (2016-2027)
• 9.2 Latin America In-vitro Diagnostic Services Market Size by Type
  • 9.2.1 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2021)
  • 9.2.2 Latin America In-vitro Diagnostic Services Market Size by Type (2022-2027)
  • 9.2.3 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2027)
• 9.3 Latin America In-vitro Diagnostic Services Market Size by Application
  • 9.3.1 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2021)
  • 9.3.2 Latin America In-vitro Diagnostic Services Market Size by Application (2022-2027)
  • 9.3.3 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2027)
• 9.4 Latin America In-vitro Diagnostic Services Market Size by Country
  • 9.4.1 Latin America In-vitro Diagnostic Services Market Size by Country (2016-2021)
  • 9.4.2 Latin America In-vitro Diagnostic Services Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2016-2027)
• 10.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type
  • 10.2.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2027)
• 10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application
  • 10.3.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2027)
• 10.4 Middle East & Africa In-vitro Diagnostic Services Market Size by Country
  • 10.4.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 BioRad
  • 11.1.1 BioRad Company Details
  • 11.1.2 BioRad Business Overview
  • 11.1.3 BioRad In-vitro Diagnostic Services Introduction
  • 11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.1.5 BioRad Recent Development
• 11.2 DexCom
  • 11.2.1 DexCom Company Details
  • 11.2.2 DexCom Business Overview
  • 11.2.3 DexCom In-vitro Diagnostic Services Introduction
  • 11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.2.5 DexCom Recent Development
• 11.3 Nova Biomedical
  • 11.3.1 Nova Biomedical Company Details
  • 11.3.2 Nova Biomedical Business Overview
  • 11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
  • 11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.3.5 Nova Biomedical Recent Development
• 11.4 OraSure
  • 11.4.1 OraSure Company Details
  • 11.4.2 OraSure Business Overview
  • 11.4.3 OraSure In-vitro Diagnostic Services Introduction
  • 11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.4.5 OraSure Recent Development
• 11.5 Pearl Pathways
  • 11.5.1 Pearl Pathways Company Details
  • 11.5.2 Pearl Pathways Business Overview
  • 11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
  • 11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.5.5 Pearl Pathways Recent Development
• 11.6 Phenomenex
  • 11.6.1 Phenomenex Company Details
  • 11.6.2 Phenomenex Business Overview
  • 11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
  • 11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.6.5 Phenomenex Recent Development
• 11.7 Qiagen
  • 11.7.1 Qiagen Company Details
  • 11.7.2 Qiagen Business Overview
  • 11.7.3 Qiagen In-vitro Diagnostic Services Introduction
  • 11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.7.5 Qiagen Recent Development
• 11.8 Roche Diagnostics
  • 11.8.1 Roche Diagnostics Company Details
  • 11.8.2 Roche Diagnostics Business Overview
  • 11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
  • 11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.8.5 Roche Diagnostics Recent Development
• 11.9 Siemens
  • 11.9.1 Siemens Company Details
  • 11.9.2 Siemens Business Overview
  • 11.9.3 Siemens In-vitro Diagnostic Services Introduction
  • 11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.9.5 Siemens Recent Development
• 11.10 Sysmex
  • 11.10.1 Sysmex Company Details
  • 11.10.2 Sysmex Business Overview
  • 11.10.3 Sysmex In-vitro Diagnostic Services Introduction
  • 11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.10.5 Sysmex Recent Development
• 11.11 Thermofisher
  • 11.11.1 Thermofisher Company Details
  • 11.11.2 Thermofisher Business Overview
  • 11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
  • 11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2016-2021)
  • 11.11.5 Thermofisher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer